Joint

Joint EBIT Growth

The Year-over-Year EBIT Growth of Joint (JYNT) as of Nov 21, 2026 is 52.07 %. In the previous year, Year-over-Year EBIT Growth was -693.48 % — a change of -107.51% (higher).

EBIT Growth

52.07 %

YoY

-107.51%

Last updated:

Year-over-Year EBIT Growth of Joint is 2025 52.07 % . Year-over-Year EBIT Growth of Joint was 2024 -693.48 % . It decreases by -107.51% higher compared to the previous year.

The Joint EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
106.46 USD
Jan 1, 2019
1,564.75 USD
Jan 1, 2020
60.84 USD
Jan 1, 2021
11.54 USD
Jan 1, 2022
-86.48 USD
Jan 1, 2023
-61.57 USD
Jan 1, 2024
-693.48 USD
Jan 1, 2025
52.07 USD
The Joint EBIT Growth history
YEAREBIT GrowthYoY
52.07 %-107.51%
-693.48 %+1,026.32%
-61.57 %-28.80%
-86.48 %-849.34%
11.54 %-81.03%
60.84 %-96.11%
1,564.75 %+1,369.79%
106.46 %+34.99%
78.87 %-228.76%
-61.25 %-87.04%
-472.72 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Joint Stock analysis

What does Joint do? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Joint stock

Year-over-Year EBIT Growth of Joint is 52.07 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Joint since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Joint historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Joint

All Key Metrics — Joint